Table of Contents

company-logo

Boditech Med Inc. develops products for in-vitro diagnostics and diagnostic reagents. It offers ichroma II, an automatic or semiautomatic in-vitro diagnostic device that measures the concentration of analytes, contained in blood, urine, or other samples, in quantitative, or semi-quantitative ways; automated fluorescent immunoassay systems under AFIAS-6 and AFIAS-1 names that uses blood, urine, and other samples to measure quantitatively or semi-quantitatively the concentration of targeted analytes; ichroma-50, an automatic immunoassay analyzer that measures the concentration of targeted analytes in body fluids, such as blood, urine, and other samples; and ichroma M2, a portable analyzer intended to be used with in vitro diagnostic immunofluorescent assay kits for screening, monitoring and/or examining routine physics in centralized laboratories of hospitals or physician's clinics. The company also provides Ichroma TRIAS Reader, an in vitro diagnostic device that measures the concentration of targeted analyte from various samples, such as blood, nasal swabs, and nasopharyngeal swabs; Hemochroma PLUS, an in vitro diagnostic device to quantitative test total hemoglobin concentration in the blood; i-chamber, an auxiliary device for the ichroma systems; and HandyRay, a laser device for the capillary blood sampling without a needle. Its solutions cover areas, such as cardiac, cancer, diabetes, hormone, infection, infectious disease, gastrointestinal, rheumatoid arthritis, and others. The company offers its products through a network of approximately 100 sales agencies worldwide. Boditech Med Inc. was founded in 1998 and is headquartered in Chuncheon, South Korea.

Boditech Med Dividend Announcement

• Boditech Med announced a annually dividend of ₩200.00 per ordinary share which will be made payable on 2024-04-22. Ex dividend date: 2024-03-29
• Boditech Med annual dividend for 2024 was ₩200.00
• Boditech Med annual dividend for 2023 was ₩150.00
• Boditech Med's trailing twelve-month (TTM) dividend yield is 2.27%
• Boditech Med's payout ratio for the trailing twelve months (TTM) is 14.44%
• Boditech Med's dividend growth over the last five years (2018-2023) was 24.57% year

Boditech Med Dividend History

Ex-Div dateDividend amountDividend typePay date
2024-03-29₩200.00annually2024-04-22
2023-12-27₩150.00annually
2022-12-28₩150.00annually2023-04-12
2021-12-29₩200.00annually2022-04-11
2020-12-29₩200.00annually2021-04-19
2019-12-27₩50.00annually2020-04-17
2018-12-27₩50.00annually2019-04-15
2017-12-27₩50.00annually2018-04-13
2016-12-28₩110.00annually

Boditech Med Dividend per year

Boditech Med Dividend growth

Boditech Med Dividend Yield

Boditech Med current trailing twelve-month (TTM) dividend yield is 2.27%. Interested in purchasing Boditech Med stock? Use our calculator to estimate your expected dividend yield:

Boditech Med Financial Ratios

P/E ratio11.21
PEG ratio-0.10
P/B ratio1.64
ROE15.91%
Payout ratio14.44%
Current ratio5.51
Quick ratio4.17
Cash Ratio1.42

Boditech Med Dividend FAQ

Does Boditech Med stock pay dividends?
Boditech Med does not currently pay dividends to its shareholders.
Has Boditech Med ever paid a dividend?
No, Boditech Med has no a history of paying dividends to its shareholders. Boditech Med is not known for its dividend payments.
Why doesn't Boditech Med pay dividends?
There are several potential reasons why Boditech Med would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Boditech Med ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Boditech Med has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Boditech Med a dividend aristocrat?
Boditech Med is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Boditech Med a dividend king?
Boditech Med is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Boditech Med a dividend stock?
No, Boditech Med is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Boditech Med stocks?
To buy Boditech Med you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Boditech Med stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.